Ribbed container
Number of patents in Portfolio can not be more than 2000
United States of America Design
Stats
-
Nov 19, 1996
Grant Date -
N/A
app pub date -
May 26, 1995
filing date -
May 26, 1995
priority date (Note) -
Expired
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance
Loading Importance Indicators...

Calculated Rating
US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
Not Available
First Claim
all claims..Other Claims data not available
Family
Loading Family data...

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
PACKAGING CORPORATION OF AMERICA | 1955 WEST FIELD COURT LAKE FOREST IL 60045 |
International Classification(s)
- Non-US Classification not provided for expired patents
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Schoff, David C | Ripon, WI | 1 | 54 |
# of filed Patents : 1 Total Citations : 54 |
Cited Art Landscape
- No Cited Art to Display
Loading Cited Art Landscape... 

Patent Citation Ranking
- Citation Ranking not provided for expired patents
Forward Cite Landscape
- No Forward Cites to Display
Loading Forward Cite Landscape... 

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text
US Patent No: 9624262
Plasma protein fractionation by sequential polyacid precipitation
Abstract
There is a recognized need for novel, more simplified, approaches to isolation of plasma from whole blood, as well as a need to isolate cell-free plasma fractions containing different plasma proteins. Methods are divulged for use of aqueous phase systems, formed in blood or blood containing solutions via addition of a single polymer at relatively low concentration, to effect isolation (clarification) of plasma proteins from blood cells. Methods are also divulged to replace widely used Cohn-type plasma protein fractionation which is based on sequential addition of up to 40% (v/v) ethanol and other precipitants, with simple sequential addition of a polyacid. The latter results in isolation of plasma protein fractions (i.e. fibrinogen, immunoglobulin, albumin) in sequence similar to that obtained with Cohn Fractionation and therefore may be suitable for use to reduce solvent use and solvent-related process complications in existing plasma protein purification processes. It may also support use of polymeric film based containers in novel solvent free plasma fractionation processes. The methods disclosed may also be suitable for use in smaller scale plasma protein isolation, in research and diagnostic applications. The general methodologies are robust and can function over a broad range of process variables such as temperature and pH.
Description
Claims
Claims data not available

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Oct 02, 2024 | MAFP | MAINTENANCE FEE PAYMENT | free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 8 |
Sep 18, 2020 | MAFP | MAINTENANCE FEE PAYMENT | free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 4 |
Jun 17, 2020 | AS | ASSIGNMENT | free format text: CHANGE OF NAME;ASSIGNOR:GE HEALTHCARE BIOPROCESS R&D AB;REEL/FRAME:054299/0349 Owner name: CYTIVA BIOPROCESS R&D AB, SWEDEN Effective Date: Jun 17, 2020 |
Apr 18, 2017 | I | Issuance | |
Mar 29, 2017 | STCF | INFORMATION ON STATUS: PATENT GRANT | free format text: PATENTED CASE |
Dec 18, 2015 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GE HEALTHCARE BIO-SCIENCES AB;REEL/FRAME:038811/0001 Owner name: GE HEALTHCARE BIOPROCESS R&D AB, SWEDEN Effective Date: Dec 18, 2015 |
Nov 20, 2014 | P | Published | |
Mar 17, 2014 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VAN ALSTINE, JAMES;BERG, MIKAEL;SHANAGAR, JAMIL;AND OTHERS;SIGNING DATES FROM 20120919 TO 20120928;REEL/FRAME:032452/0716 Owner name: GE HEALTHCARE BIO-SCIENCES AB, SWEDEN |
Sep 14, 2012 | F | Filing | |
Sep 16, 2011 | PD | Priority Date |

Matter Detail

Country:
Application No:
Patent No:
Application Publication No:
Status:
Priority Date:
Filing Date:
Matter Type:
Local Registration No:
Docket No:
Secondary System Identifier (SSI):
Customer Application No:
Filing Type:
Request for Examination Date:
Parent Filing Date:
Complete Specification Date:
PCT Filing Date:
National Entry Date:
First Publication Date:
Allowance Date:
Grant Date:
Grant Publication Date:
Claims:
Independent Claims:
Law Firm:
Renewals Detail

Applicant:
Applicant ID:
Entity Size:
Renewal Status:
Renewal Base Date:
Renewal Trigger Date: